0

Ilmofosine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP83519044
CAS83519-04-4
Structure
MDL NumberMFCD00869023
Molecular Weight525.77
InChI KeyODEDPKNSRBCSDO-UHFFFAOYSA-N
Description≥97% (NMR), semisolid (waxy)
SolubilityH2O: 10 mg/mL
Assay≥97% (NMR)
Formsemisolid (waxy)
Size1MG
Storage Conditions−20°C
1

Aspects of the Cytological Activity of Edelfosine, Miltefosine, and Ilmofosine in Leishmania Donovani

S Azzouz, M Maache, M F Dos Santos, M E Sarciron, A F Petavy, A Osuna

J Parasitol. 2006 Oct;92(5):877-83.

PMID: 17152926

1

Effect of the Lysophospholipid Analogues Edelfosine, Ilmofosine and Miltefosine Against Leishmania Amazonensis

Ricardo M Santa-Rita, Andréa Henriques-Pons, Helene S Barbosa, Solange L de Castro

J Antimicrob Chemother. 2004 Oct;54(4):704-10.

PMID: 15329361

1

In Vitro Activities of Adamantylidene-Substituted Alkylphosphocholine TCAN26 Against Trypanosoma Cruzi: Antiproliferative and Ultrastructural Effects

Emile Barrias, Lissa Catherine Reignault, Theodora Calogeropoulou, Wanderley de Souza

Exp Parasitol. 2019 Nov;206:107730.

PMID: 31494215

1

Phase I and Pharmacokinetic Study of the Cytotoxic Ether Lipid Ilmofosine Administered by Weekly Two-Hour Infusion in Patients With Advanced Solid Tumors

Bruce J Giantonio, Christine Derry, Cecilia McAleer, Joseph J McPhillips, Peter J O'Dwyer

Clin Cancer Res. 2004 Feb 15;10(4):1282-8.

PMID: 14977826

1

Resistance to the New Anti-Cancer Phospholipid Ilmofosine (BM 41 440)

J Hofmann, I Utz, M Spitaler, S Hofer, M Rybczynska, W T Beck, D B Herrmann, H Grunicke

Br J Cancer. 1997;76(7):862-9.

PMID: 9328144

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode